Phase III Intergroup Study of Radiotherapy with Concomitant and Adjuvant
Temozolomide versus Radiotherapy with Adjuvant PCV Chemotherapy in Patients with lp/19q Co-deleted Anaplastic Glioma or Low Grade Glioma
*For Eligibility information, look up the trial at NIH by clicking on the Study Number above.*
Other eligibility criteria may apply.
Other exclusion criteria may apply.